363 related articles for article (PubMed ID: 16687489)
1. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
Wischnewski F; Pantel K; Schwarzenbach H
Mol Cancer Res; 2006 May; 4(5):339-49. PubMed ID: 16687489
[TBL] [Abstract][Full Text] [Related]
2. Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism.
Hou SY; Sang MX; Geng CZ; Liu WH; Lü WH; Xu YY; Shan BE
Arch Med Res; 2014 Jan; 45(1):44-51. PubMed ID: 24316396
[TBL] [Abstract][Full Text] [Related]
3. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
4. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
5. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
7. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.
Fahrner JA; Eguchi S; Herman JG; Baylin SB
Cancer Res; 2002 Dec; 62(24):7213-8. PubMed ID: 12499261
[TBL] [Abstract][Full Text] [Related]
8. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.
Liu Y; Hong Y; Zhao Y; Ismail TM; Wong Y; Eu KW
Cancer Invest; 2008 Jul; 26(6):575-82. PubMed ID: 18584348
[TBL] [Abstract][Full Text] [Related]
9. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
[TBL] [Abstract][Full Text] [Related]
10. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells.
Meng CF; Su B; Li W
Mol Med Rep; 2011; 4(6):1273-8. PubMed ID: 21850374
[TBL] [Abstract][Full Text] [Related]
11. [Expression of neprilysin gene is associated with methylation and histone modification on promoter in mouse neuroblastoma Neuro-2a cells].
Deng Y; Lu X; Liu L; Li T; Zhang Y; Guo X; Yu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):810-3. PubMed ID: 25108432
[TBL] [Abstract][Full Text] [Related]
12. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
[TBL] [Abstract][Full Text] [Related]
13. Expression spectrum and methylation-dependent regulation of melanoma antigen-encoding gene family members in pancreatic cancer cells.
Bert T; Lubomierski N; Gangsauge S; Münch K; Printz H; Prasnikar N; Robbel C; Simon B
Pancreatology; 2002; 2(2):146-54. PubMed ID: 12123095
[TBL] [Abstract][Full Text] [Related]
14. Heparanase expression is associated with histone modifications in glioblastoma.
Hong X; Nelson K; Lemke N; Kalkanis SN
Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
Bai T; Tanaka T; Yukawa K; Umesaki N
Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
18. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.
Karpf AR; Lasek AW; Ririe TO; Hanks AN; Grossman D; Jones DA
Mol Pharmacol; 2004 Jan; 65(1):18-27. PubMed ID: 14722233
[TBL] [Abstract][Full Text] [Related]
19. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF
PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
